Literature DB >> 24995736

Efficacy of selected treadmill training programme on oxidative stress in adolescents with Down syndrome.

N A Meguid1, A M Eltohamy2, M Anwar1, A F Hashish1, A Elnahry1.   

Abstract

The aim of this study was to assess the efficacy of an electronic treadmill exercise training programme on malondialdehyde (MDA) as a marker for lipid peroxidation and the antioxidant enzyme glutathione peroxidase (GPx) in adolescents with Down syndrome. The study was carried out on 30 adolescent males with Down syndrome, ranging in age from 15 to 18 years, with 30 healthy subjects as a control group. Clinical examination, anthropometric measurements and determination of GPx activity and MDA before and after exercise were done. A treadmill training programme was performed for 12 weeks. Our data showed a significant increase in GPx activity and decrease in serum level of MDA in Down syndrome individuals after treadmill exercise for 3 months. Exercise promotion for adolescents with Down syndrome requires attention to motivators and facilitators of exercise adherence as it may limit risk of increased neurological consequences associated with oxidative stress and improve quality of life.

Entities:  

Year:  2014        PMID: 24995736

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  2 in total

1.  Exposure assessment of children living in homes with hookah smoking parents to polycyclic aromatic hydrocarbons: urinary level, exposure predictors, and risk assessment.

Authors:  Zeynab Tabatabaei; Narges Shamsedini; Amin Mohammadpour; Mohammad Ali Baghapour; Mohammad Hoseini
Journal:  Environ Sci Pollut Res Int       Date:  2022-05-11       Impact factor: 5.190

Review 2.  Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.

Authors:  Dominik Szwajgier; Ewa Baranowska-Wójcik; Joanna Grzelczyk; Wioletta Żukiewicz-Sobczak
Journal:  Dis Markers       Date:  2021-06-28       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.